October 21, 2010 |
Pfizer Inc.'s hormones, once used by millions of women to ease menopause symptoms, almost doubled the death risk from breast cancer, a U.S. study found. The findings from the U.S.-funded Women's Health Initiative are the first to tie Pfizer's hormone replacement therapy Prempro, already linked to higher rates of breast cancer and heart disease, to increased mortality from tumors. Pfizer, the world's largest drugmaker, on Tuesday won its sixth of 13 jury cases over Prempro's health risks an hour before the research was reported by the Journal of the American Medical Association.
March 25, 1991 |
Women with advanced breast cancer will have an opportunity to participate in an experimental bone marrow transplant program, representatives of four Philadelphia hospitals were set to announce today. Under a unique arrangement, U.S. Healthcare will approve admission of its members to this program. Many private insurance carriers reject their subscribers' requests for bone marrow transplants as being experimental and not regarded as standard care. The cooperative venture involving Hahnemann and Temple universities, the University of Pennsylvania and Fox Chase Cancer Center was developed over the past year.
March 19, 1987 |
The television commercial opens with a shot of a middle-aged man's troubled face. "I used to think I wasn't afraid of anything," the man says. What did scare him, he adds, was that his wife got breast cancer. The commercial's unconventional approach to advertising for treatment of breast cancer and the emotional struggle surrounding the disease focuses on the husband and only later does the wife come in. The commercial for Albert Einstein Medical Center's Breast Cancer Center will make its debut on television tonight and will be accompanied by a radio and print campaign.
October 3, 2011 |
For breast cancer survivors like Marie McCrone, the worry never quite stops. Despite a lumpectomy and lymph node removal in 2002, she feared recurrence of the cancer or the onset of lymphedema, a painful swelling of the arm that can occur long after surgery. "I heard all sorts of horror stories about it," recalls McCrone, 52, of Warrington, Bucks County. "How you might get it just from lifting a grocery bag. " Four years later, she heard about a weightlifting program for breast cancer survivors being tested at the University of Pennsylvania..
March 26, 2001 |
Seven years ago, a Canadian sports-medicine physician set out to show that breast cancer patients can benefit from exercise. And not just any exercise. Donald McKenzie was advocating strenuous, repetitive, resistance-oriented arm movement - the very kind such patients are usually told to avoid. So he formed a dragon boat team, called Abreast in a Boat. On Thursday evening, McKenzie will be at Main Line Health and Fitness Center to describe the success of that team, which has inspired the creation of dozens more in Canada and other countries.
January 3, 1992 |
The powerful but, some say, dangerous drug tamoxifen can prolong the lives of women with breast cancer following a mastectomy, researchers said today. In the most extensive review of its kind ever undertaken, scientists compiled data involving 75,000 women who had participated in 133 trials worldwide. The review, published in the British medical journal Lancet, showed that a combined treatment of tamoxifen and chemotherapy after surgery had the greatest effect on women with advanced breast cancer.
June 5, 1988 |
There were a lot of laughs over a new type of breast prosthesis - one with fittings involving Saran wrap, Pam spray and a plaster-type substance. At the Brandywine Hospital ABC Support Group, the laughs are the flip side of tears women sometimes shed, trying to combat their feelings of loss and mortality after mastectomies. The feelings remain, but women can now share them with others in the Brandywine group, the only support group in Chester County specifically for women who have had breast surgery.
December 9, 2011 |
SAN ANTONIO - Doctors were mostly hoping to prevent complications and relapses when they gave young women a medicine to keep their bones strong during breast cancer treatment. Seven years later, they found it did more than that: The bone drug improved survival, as much as many chemotherapies do. The study found a 37 percent lower risk of death among women who received the bone drug, Zometa. In absolute terms, it meant that four to five more women out of every 100 were alive seven years later.
May 14, 2001 |
They began arriving just after dawn yesterday, and by 8 a.m., more than 2,000 people - in pink hats and pink T-shirts, carrying pink carnations or wearing them in their hair - were gathered at the top of the Art Museum steps. On a day that was both upbeat and tearful, they smiled broadly, clasped hands, raised them high and marched down. It was a river of pink - young women and old, smooth-faced and wrinkled, women with thick hair, thinning hair, just-growing-back hair . . . grandmothers, mothers, daughters, wives, sisters, aunts, nieces, and even a few men . . . All breast-cancer survivors.
December 27, 1994 |
Charlene Cunningham, 29, who faced terminal breast cancer with remarkable grace and spirit and whose story inspired others, died Saturday of the disease. Ms. Cunningham, of Center City, learned she had the disease in 1991 - becoming one of a small number of women who develop the disease in their 20s. She lived nearly two years longer than her doctors had predicted, in large part because of a "tremendous desire to live . . . her tremendous energy," said Pennsylvania Hospital oncologist David Mintzer.